Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 239

Similar articles for PubMed (Select 17657247)

1.

Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice.

Olasz EB, Roh J, Yee CL, Arita K, Akiyama M, Shimizu H, Vogel JC, Yancey KB.

J Invest Dermatol. 2007 Dec;127(12):2807-17. Epub 2007 Jul 26.

2.

Transient anti-CD40L co-stimulation blockade prevents immune responses against human bullous pemphigoid antigen 2: implications for gene therapy.

Lanschuetzer CM, Olasz EB, Lazarova Z, Yancey KB.

J Invest Dermatol. 2009 May;129(5):1203-7. doi: 10.1038/jid.2008.364. Epub 2008 Nov 27.

3.

Sequential intramolecular epitope spreading of humoral responses to human BPAG2 in a transgenic model.

Di Zenzo G, Calabresi V, Olasz EB, Zambruno G, Yancey KB.

J Invest Dermatol. 2010 Apr;130(4):1040-7. doi: 10.1038/jid.2009.309. Epub 2009 Oct 8.

4.

A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen.

Ujiie H, Shibaki A, Nishie W, Sawamura D, Wang G, Tateishi Y, Li Q, Moriuchi R, Qiao H, Nakamura H, Akiyama M, Shimizu H.

J Immunol. 2010 Feb 15;184(4):2166-74. doi: 10.4049/jimmunol.0903101. Epub 2010 Jan 20.

5.

Transcutaneous gene gun delivery of hNC16A Induces BPAG2-specific tolerance.

Ettinger M, Peckl-Schmid D, Gruber C, Laimer M, Thalhamer J, Hintner H, Gratz IK, Bauer JW.

J Invest Dermatol. 2012 Jun;132(6):1665-71. doi: 10.1038/jid.2012.19. Epub 2012 Mar 1.

6.

Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.

Shimanovich I, Mihai S, Oostingh GJ, Ilenchuk TT, Bröcker EB, Opdenakker G, Zillikens D, Sitaru C.

J Pathol. 2004 Dec;204(5):519-27.

PMID:
15538734
7.
8.

Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid.

Yamamoto K, Inoue N, Masuda R, Fujimori A, Saito T, Imajoh-Ohmi S, Shinkai H, Sakiyama H.

J Invest Dermatol. 2002 Mar;118(3):485-92.

9.
10.

The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane.

Masunaga T, Shimizu H, Yee C, Borradori L, Lazarova Z, Nishikawa T, Yancey KB.

J Invest Dermatol. 1997 Aug;109(2):200-6.

PMID:
9242508
11.

Precise ultrastructural localization of in vivo deposited IgG antibodies in fresh perilesional skin of patients with bullous pemphigoid.

Sato M, Shimizu H, Ishiko A, Masunaga T, Akiyama M, Hashimoto T, Kitajima Y, Nishikawa T.

Br J Dermatol. 1998 Jun;138(6):965-71.

PMID:
9747356
12.

Molecular cloning of canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies.

Xu L, O'Toole EA, Olivry T, Hernandez C, Peng J, Chen M, Chan LS.

Biochim Biophys Acta. 2000 Jan 3;1500(1):97-107.

13.

IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment.

Iwata H, Kamio N, Aoyama Y, Yamamoto Y, Hirako Y, Owaribe K, Kitajima Y.

J Invest Dermatol. 2009 Apr;129(4):919-26. doi: 10.1038/jid.2008.305. Epub 2009 Jan 29.

15.

Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice.

Zillikens D, Schmidt E, Reimer S, Chimanovitch I, Hardt-Weinelt K, Rose C, Bröcker EB, Kock M, Boehncke WH.

J Pathol. 2001 Jan;193(1):117-24.

PMID:
11169524
16.

Difference in binding sites of autoantibodies against 230- and 170-kD bullous pemphigoid antigens on salt-split skin.

Onodera Y, Shimizu H, Hashimoto T, Ishiko A, Ebihara T, Tanaka M, Nishikawa T.

J Invest Dermatol. 1994 May;102(5):686-90.

PMID:
8176249
17.

Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.

Sitaru C, Schmidt E, Petermann S, Munteanu LS, Bröcker EB, Zillikens D.

J Invest Dermatol. 2002 Apr;118(4):664-71.

18.

Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model.

Ujiie H, Shibaki A, Nishie W, Shinkuma S, Moriuchi R, Qiao H, Shimizu H.

Clin Immunol. 2012 Feb;142(2):167-75. doi: 10.1016/j.clim.2011.10.002. Epub 2011 Oct 17.

PMID:
22044750
19.

Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls.

Büdinger L, Borradori L, Yee C, Eming R, Ferencik S, Grosse-Wilde H, Merk HF, Yancey K, Hertl M.

J Clin Invest. 1998 Dec 15;102(12):2082-9.

20.

Lichen planus pemphigoides with IgG autoantibodies to the 180 kd bullous pemphigoid antigen (type XVII collagen).

Hsu S, Ghohestani RF, Uitto J.

J Am Acad Dermatol. 2000 Jan;42(1 Pt 1):136-41.

PMID:
10607335
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk